Moneycontrol PRO
you are here: HomeNewsIndia

COVID-19 third wave inevitable, could strike India in 6-8 weeks: AIIMS chief

The arrival of the third wave could be expedited through the violation of COVID-appropriate behaviour, Dr Randeep Guleria said.

June 20, 2021 / 08:43 AM IST
India witnessed a shortage in medical oxygen during the second wave (Representative image: Reuters)

India witnessed a shortage in medical oxygen during the second wave (Representative image: Reuters)

Chief of All India Institute of Medical Sciences (AIIMS), Dr Randeep Guleria, on June 19 said the third wave of COVID-19 could hit India in the next "six to eight weeks." Noting that the virus causing SARS-CoV-2 infection is still mutating, Dr Guleria claimed that a third wave of the pandemic is "inevitable".

The remarks of the AIIMS director comes days after the detection of the 'Delta-plus' variant of coronavirus, which is feared to drive the third round of the health crisis.

Although a new wave strikes usually in a three-month period, the arrival of the third wave could be expedited through the violation of COVID-appropriate behaviour, Dr Guleria said while speaking to NDTV.

"We don't seem to have learnt from what happened between the first and the second wave. Again crowds are building up... people are gathering. It will take some time for the number of cases to start rising at the national level. The third wave is inevitable and it could hit the country within the next six to eight weeks... maybe a little longer," he told the news channel.

Also Read | Delta plus variant may set off third COVID-19 wave in Maharashtra, active cases may top 8 lakh: Health Department


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The AIIMS chief also suggested that micro-management of the virus could reduce the impact of the COVID-19 third wave. "Mini-lockdowns" need to be strictly enforced in areas with over a five percent positivity rate, he said, adding that aggressive surveillance is also required in hotspots to track down the new variants.

Dr Guleria also indicated that mass vaccination would be essential in minimising the impact of the third wave. "Unless we're vaccinated, we're vulnerable in the coming months," he said.

Around five percent of the country's population has been vaccinated so far with both doses of the COVID-19 vaccine. The government aims to vaccinate over 100 crore citizens by the end of 2021.

The vaccination schedule for Covishield - the jab which is being currently provided to over 80 percent beneficiaries - was changed last month. The gap between the two doses was extended to 12-16 weeks. Experts say it will allow the government to widen the coverage of immunisation drive by at least providing the first dose to the eligible beneficiaries.

"One-shot strategy may not be a bad strategy as it can give protection to larger number of people," Dr Guleria said. However, he noted that the decision to extend the dose gap should be driven by science and not due to a shortage of doses.

The second COVID-19 wave in India was witnessed between March-end, and the peak was considered to have been passed in mid-May. Between April and May, the country reported an unprecedented surge in infections. The per-day count had peaked above 4 lakh, whereas, the daily fatality count had also crossed the grim 4,000-mark.

Over the past month, India has witnessed a rapid decline in the daily case count. On June 19, 60,753 fresh infections were reported along with 1,647 deaths. The active case count plunged to its lowest in the past 74 days, and was reported as 7,60,019.
Moneycontrol News

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark